Medication for Depression: Options, Reviews and Next Steps

Medication can reduce depressive symptoms and support recovery, but the choice should reflect severity, previous response, physical health, and preferences. Psychological treatment and practical support remain important. A good prescribing plan explains the expected benefit, early adverse effects, follow-up, and what happens if the first option does not help.

Assessment shapes the treatment choice

Low mood can occur with depression, bipolar disorder, grief, substance use, medical illness, and other problems. An assessment should consider duration, functioning, sleep, appetite, safety, and any history of unusually increased activity or reduced need for sleep. The diagnosis influences which medication approach is appropriate.

For less severe depression, medication may not be the preferred first option unless it fits an informed preference or other circumstances. More severe symptoms may justify medication, psychological treatment, or a combination. Shared decisions should consider access and the person's ability to participate in the proposed plan.

Common medication groups

What to expect after starting

Benefit usually develops over time rather than after the first dose. Early nausea, sleep changes, or activation may appear before mood improvement. The prescriber should arrange follow-up to assess tolerability and safety, then review whether the trial has meaningfully improved symptoms and daily life.

Track a few practical outcomes, such as getting out of bed, completing essential tasks, reconnecting with people, or recovering interest. Ask when to contact the team about worsening mood, agitation, or suicidal thoughts. Immediate danger requires urgent help rather than waiting for a routine review.

Match adverse-effect priorities to the person

Sexual effects, weight changes, sleepiness, insomnia, and emotional blunting can affect whether treatment remains acceptable. Previous experience is valuable information. The goal is not to tolerate every unwanted effect because a medicine is commonly used, but to weigh benefit and burden together.

Other medicines, pregnancy plans, seizure history, liver or kidney disease, and cardiovascular concerns may change the choice. A pharmacist can check the full combination. Do not assume that a brand used for another condition has identical instructions or can be added safely.

When the first treatment does not help enough

A review should examine diagnosis, consistency of use, trial duration, dose adequacy, adverse effects, and ongoing stressors. A lack of improvement does not automatically mean all antidepressants will fail. Options can include psychological treatment, a supported switch, or specialist combination or augmentation strategies.

Persistent depression may require a more detailed assessment. Specialist treatments have specific eligibility and monitoring needs and should not be presented as universal next steps. Discuss what outcome the proposed change is expected to improve and how the team will know whether it worked.

Continuation and stopping need a plan

Medication may be continued after improvement to reduce recurrence risk, with duration individualized to episode history, residual symptoms, and preference. Reviews should remain active rather than becoming automatic prescription renewals. Feeling better is a reason to discuss the longer-term plan, not proof that stopping is immediately safe.

Antidepressant withdrawal can follow missed doses or reduction and may resemble returning depression. A supported, gradual change may be needed. Do not independently stop or double medication; record the timing of symptoms and ask the prescriber to assess withdrawal, recurrence, or both.

Depression assessment should look beyond the current low mood

Before choosing an antidepressant, tell the clinician about previous periods of unusually elevated mood, markedly reduced need for sleep or impulsive behavior. These can affect whether a bipolar assessment is needed. Substance use, physical illness, medication effects and major life circumstances may also contribute to depressive symptoms. A medicine name should follow an assessment rather than replace it.

The depression treatment guide explains broader care. Describe the duration, impact and previous episodes, including what happened with earlier treatment. Ask what the team believes the diagnosis is and what uncertainty remains. The same symptom of low mood can arise in different clinical situations, and a treatment appropriate for one is not automatically appropriate for all. If risk is immediate or symptoms deteriorate severely, urgent assessment takes priority over waiting for a routine medication trial. A clear diagnosis and safety plan make the subsequent comparison of options more meaningful.

Choosing around sleep, appetite and sexual well-being

Antidepressants have different average effect profiles, while individual experience remains variable. Sleep disturbance, appetite changes, sexual symptoms, pain and other priorities can influence the discussion. Tell the prescriber which effects would be especially difficult and which symptoms most impair life. A medication that suits another person's sleep pattern may not fit yours.

The sertraline profile and mirtazapine guide describe two distinct options, while the antidepressant overview places them in context. Avoid a strongest-to-weakest ranking or a promise that a particular drug cannot cause an effect. The clinician should also review interactions, age, pregnancy plans and medical conditions. A useful choice compares the likely benefits and burdens with feasible alternatives and your preferences. If a troublesome effect emerges, discuss it instead of assuming the only options are tolerating it indefinitely or stopping abruptly. Quality of life belongs in the assessment alongside symptom improvement.

Partial response is different from no response

A person may sleep better and regain energy while still experiencing low mood, avoidance or loss of interest. Another may feel no useful change because the medicine was difficult to take consistently. These are different situations. Describe what improved, what remained and how treatment was actually used so the clinician can interpret the trial accurately.

A review may consider diagnosis, duration, tolerability, practical adherence, psychological treatment and another condition before deciding the next medication step. Do not increase the amount or add an old prescription independently. Switching and augmentation have different risks and requirements, especially with serotonergic combinations or specialist medicines. The team should explain why the proposed change fits the remaining problem and how it will be measured. Treatment-resistant depression is not simply a label for one difficult week or a medicine stopped early because of nausea. An accurate history helps identify appropriate options without overstating what previous trials established.

Continuation, relapse prevention and a planned stop

After improvement, continuing treatment may be recommended to reduce recurrence risk. The decision depends on the episode history, residual symptoms, severity, previous relapse and preferences. Feeling better can be an intended benefit rather than proof that the prescription is unnecessary. Ask when continuing need will be reviewed and what other support can help sustain recovery.

If stopping is appropriate, a clinician-led plan should consider withdrawal and recurrence. New physical symptoms after a reduction may need assessment rather than automatically be labeled a return of depression. Do not use alternate-day dosing or a copied taper schedule without advice. A plan should include what symptoms to report, follow-up and whom to contact. Psychological treatment, routines and social support remain relevant during continuation or reduction. The aim is an informed decision that protects recovery while respecting the person's concerns, rather than indefinite prescribing without review or an abrupt stop used as a test of whether depression has ended.

Making the next medication discussion useful

Bring one current list of medicines to the appointment, including the exact product, prescribed instructions, over-the-counter remedies, supplements and any medicines you take only occasionally. If the list in a clinic record is different from what you actually use, say so. Understanding the difference is more useful than trying to give an answer that sounds correct. A photograph of packaging can help clarify an unfamiliar brand or formulation.

Choose two or three priorities before the visit. These might be a persistent symptom, a side effect affecting daily life, a monitoring result or concern about continuing treatment. Describe when the problem began and whether it followed a change in medicine, illness, sleep or substance use. You do not have to diagnose the cause yourself. A clear timeline helps the clinician consider several explanations without automatically attributing everything to the psychiatric condition.

Leave with an agreed next step and a review date. If the plan changes, ask for written instructions that explain what each medicine is intended to do and whom to contact if a problem occurs. Check that the pharmacy and other prescribers have the updated plan. A useful review ends with responsibilities assigned, not simply with a recommendation to monitor the situation. Shared decisions should include your preferences, the available evidence and the practical ability to carry out the plan.

Related Medication and Treatment Guides

• What are Antidepressants
• Mirtazapine: effects, sleep, weight, side effects and tapering
• Sertraline: uses, side effects and precautions
• Private Depression Treatment Center
• Explore the Medication Guide